{"doi":"10.1016/j.jalz.2006.05.2117","title":"P4–376: Application of “proteasome tolerance” to therapies for neurodegenerative disease","abstract":null,"journal":"Alzheimer's & Dementia","year":2006,"id":24540,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":146945,"name":"Takashi Kudo","orcid":null,"position":1,"is_corresponding":false},{"id":146946,"name":"Takashi Morihara","orcid":null,"position":2,"is_corresponding":false},{"id":146947,"name":"Daisuke Kanayama","orcid":null,"position":3,"is_corresponding":false},{"id":146948,"name":"Takashi Minami","orcid":null,"position":4,"is_corresponding":false},{"id":146949,"name":"Masatoshi Takeda","orcid":null,"position":5,"is_corresponding":false},{"id":146944,"name":"Nobuhiko Tabuchi","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24523987","pmcid":null,"openalex_id":"https://openalex.org/W3022694556","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.30042565,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S1552526006045006?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1552526006045006?httpAccept=text/plain","host_type":"publisher"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2006.05.2117","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2006.05.2117","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1016/j.jalz.2006.05.2117","host_type":"publisher"},{"url":"https://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2006.05.2117","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jalz.2006.05.2117","host_type":"journal"}],"fields_of_study":["Ubiquitin and proteasome pathways"],"mesh_terms":[],"keywords":["Proteasome","Lactacystin","Proteasome inhibitor","Neurodegeneration","Biology","Disease","Cell biology","Cancer research","Medicine","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-07T22:38:55.573439Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}